Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7621 USD | -0.41% |
|
-5.73% | -31.34% |
31/05 | Organovo Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
15/04 | Organovo's fatty liver disease drug meets main goal in mid-stage study | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.34% | 11M | |
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- ONVO Stock
- News Organovo Holdings, Inc.
- Organovo Holdings, Inc. Announces the Resignation of Eric David as Chief Strategy Officer and Executive Vice President of Preclinical Development, Effective December 12, 2017